Target intelligence / Profile preview

Baculoviral IAP Repeat-Containing Protein 2 (cIAP1)

Target
cIAP1
Molecular classification
E3 ubiquitin ligase, Inhibitor of Apoptosis Protein (IAP)
01

Overview

Baculoviral IAP repeat-containing protein 2 (BIRC2), also known as cIAP1, is a multifunctional protein that regulates apoptosis, inflammation, immunity, and cell signaling pathways. It inhibits apoptosis by interfering with caspase activation and functions as an E3 ubiquitin-protein ligase. It is implicated in cancer and autoimmune/inflammatory diseases, making it a potential therapeutic target.

Other names
API1MIHBIAP homolog BRING finger protein 48
02

Mechanism of action

Inhibition of caspase activation, E3 ubiquitin ligase activity, regulation of inflammatory signaling.

03

Biological functions

Apoptosis inhibitionUbiquitin-protein transferase activityRegulation of necroptosisPositive regulation of canonical NF-kappaB signal transductionModulation of inflammatory processesCell cycle regulationInnate immune response
04

Disease associations

CancerAutoimmune DiseasesInflammatory Diseases

Beyond the preview

Go deeper on Baculoviral IAP Repeat-Containing Protein 2 (cIAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baculoviral IAP Repeat-Containing Protein 2 (cIAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call